Able 0 4 0 4 B-language_fluency
to 5 7 5 7 I-language_fluency
read 8 12 8 12 I-language_fluency
and 13 16 13 16 I-language_fluency
write 17 22 17 22 I-language_fluency
English 23 30 23 30 I-language_fluency

Age 0 3 31 34 B-age
21 4 6 35 37 B-lower_bound
- 6 7 37 38 O
65 7 9 38 40 B-upper_bound

EKG 0 3 41 44 B-treatment
evidence 4 12 45 53 O
at 13 15 54 56 O
baseline 16 24 57 65 O
screening 25 34 66 75 O
of 35 37 76 78 O
any 38 41 79 82 O
clinically 42 52 83 93 O
significant 53 64 94 105 O
conduction 65 75 106 116 O
abnormalities 76 89 117 130 O
or 90 92 131 133 O
arrhythmias 93 104 134 145 B-chronic_disease

EKG 0 3 146 149 B-treatment
evidence 4 12 150 158 O
at 13 15 159 161 O
baseline 16 24 162 170 O
screening 25 34 171 180 O
of 35 37 181 183 O
any 38 41 184 187 O
clinically 42 52 188 198 O
significant 53 64 199 210 O
conduction 65 75 211 221 O
abnormalities 76 89 222 235 O
or 90 92 236 238 O
arrhythmias 93 104 239 250 B-chronic_disease
; 104 105 250 251 O
known 106 111 252 257 O
intolerance 112 123 258 269 O
for 124 127 270 273 O
guanfacine 128 138 274 284 B-treatment
or 139 141 285 287 O
any 142 145 288 291 O
alpha 146 151 292 297 B-treatment
blocker 152 159 298 305 I-treatment
; 159 160 305 306 O
history 161 168 307 314 O
of 169 171 315 317 O
fainting 172 180 318 326 B-chronic_disease
, 180 181 326 327 O
syncopal 182 190 328 336 B-chronic_disease
attacks 191 198 337 344 I-chronic_disease
, 198 199 344 345 O
heart 200 205 346 351 B-chronic_disease
failure 206 213 352 359 I-chronic_disease
or 214 216 360 362 I-chronic_disease
myocardial 217 227 363 373 I-chronic_disease
infarction 228 238 374 384 I-chronic_disease
, 238 239 384 385 O
or 240 242 386 388 O
impaired 243 251 389 397 B-chronic_disease
liver 252 257 398 403 I-chronic_disease
as 258 260 404 406 O
indicated 261 270 407 416 O
by 271 273 417 419 O
aspartate 274 283 420 429 B-clinical_variable
aminotransferase 284 300 430 446 I-clinical_variable
( 301 302 447 448 I-clinical_variable
AST 302 305 448 451 I-clinical_variable
) 305 306 451 452 I-clinical_variable

Meet 0 4 453 457 O
DSM 5 8 458 461 O
- 8 9 461 462 O
IV 9 11 462 464 O
criteria 12 20 465 473 O
for 21 24 474 477 O
current 25 32 478 485 O
( 33 34 486 487 O
past-6 34 40 487 493 B-upper_bound
month 41 46 494 499 I-upper_bound
) 46 47 499 500 O
attention 48 57 501 510 O
deficit 58 65 511 518 B-chronic_disease
hyperactivity 66 79 519 532 I-chronic_disease
disorder 80 88 533 541 I-chronic_disease
( 89 90 542 543 I-chronic_disease
ADHD 90 94 543 547 I-chronic_disease
) 94 95 547 548 I-chronic_disease

Meets 0 5 549 554 O
Diagnostic 6 16 555 565 O
and 17 20 566 569 O
Statistical 21 32 570 581 O
Manual 33 39 582 588 O
of 40 42 589 591 O
Mental 43 49 592 598 O
Disorders 50 59 599 608 O
( 60 61 609 610 O
DSM 61 64 610 613 O
- 64 65 613 614 O
IV 65 67 614 616 O
) 67 68 616 617 O
criteria 69 77 618 626 O
for 78 81 627 630 O
current 82 89 631 638 O
( 90 91 639 640 O
past 91 95 640 644 B-lower_bound
6 96 97 645 646 I-lower_bound
months 98 104 647 653 I-lower_bound
) 104 105 653 654 O
alcohol 106 113 655 662 O
abuse 114 119 663 668 O
or 120 122 669 671 O
alcohol 123 130 672 679 O
dependence 131 141 680 690 O

Suicidal 0 8 691 699 B-chronic_disease
, 8 9 699 700 O
homicidal 10 19 701 710 B-chronic_disease
or 20 22 711 713 O
evidence 23 31 714 722 O
of 32 34 723 725 O
current 35 42 726 733 O
( 43 44 734 735 O
past 44 48 735 739 B-upper_bound
6 49 50 740 741 I-upper_bound
- 50 51 741 742 I-upper_bound
month 51 56 742 747 I-upper_bound
) 56 57 747 748 O
mental 58 64 749 755 B-chronic_disease
illness 65 72 756 763 I-chronic_disease

Women 0 5 764 769 B-gender
who 6 9 770 773 O
are 10 13 774 777 O
pregnant 14 22 778 786 B-pregnancy

alanine 0 7 787 794 B-clinical_variable
aminotransferase 8 24 795 811 I-clinical_variable
( 25 26 812 813 I-clinical_variable
ALT 26 29 813 816 I-clinical_variable
) 29 30 816 817 I-clinical_variable
> 31 32 818 819 O
3x 33 35 820 822 B-lower_bound
normal 36 42 823 829 I-lower_bound
or 43 45 830 832 O
renal 46 51 833 838 O
function 52 60 839 847 O
( 61 62 848 849 O
estimated 62 71 849 858 B-clinical_variable
creatinine 72 82 859 869 I-clinical_variable
clearance 83 92 870 879 I-clinical_variable
< 93 94 880 881 O
60 94 96 881 883 B-upper_bound
cc 97 99 884 886 I-upper_bound
/ 99 100 886 887 I-upper_bound
min 100 103 887 890 I-upper_bound
) 103 104 890 891 O

known 0 5 892 897 O
intolerance 6 17 898 909 O
for 18 21 910 913 O
guanfacine 22 32 914 924 B-allergy_name
or 33 35 925 927 O
any 36 39 928 931 O
alpha 40 45 932 937 B-allergy_name
blocker 46 53 938 945 I-allergy_name

other 0 5 946 951 O
unstable 6 14 952 960 O
medical 15 22 961 968 O
conditions 23 33 969 979 O
including 34 43 980 989 O
HIV 44 47 990 993 B-chronic_disease

seizures 0 8 994 1002 B-chronic_disease

treatment 0 9 1003 1012 O
with 10 14 1013 1017 O
any 15 18 1018 1021 O
antihypertensive 19 35 1022 1038 B-treatment
drug 36 40 1039 1043 I-treatment
or 41 43 1044 1046 O
any 44 47 1047 1050 O
alpha 48 53 1051 1056 B-treatment
- 53 54 1056 1057 I-treatment
adrenergic 54 64 1057 1067 I-treatment
blocker 65 72 1068 1075 I-treatment
; 72 73 1075 1076 O
use 74 77 1077 1080 O
of 78 80 1081 1083 O
any 81 84 1084 1087 O
central 85 92 1088 1095 B-treatment
nervous 93 100 1096 1103 I-treatment
system 101 107 1104 1110 I-treatment
( 108 109 1111 1112 I-treatment
CNS 109 112 1112 1115 I-treatment
) 112 113 1115 1116 I-treatment
depressant 114 124 1117 1127 I-treatment
( 125 126 1128 1129 O
e.g. 126 130 1129 1133 O
, 130 131 1133 1134 O
phenothiazines 132 146 1135 1149 B-treatment
, 146 147 1149 1150 O
barbiturates 148 160 1151 1163 B-treatment
, 160 161 1163 1164 O
benzodiazepines 162 177 1165 1180 B-treatment
) 177 178 1180 1181 O

